<DOC>
	<DOCNO>NCT01614483</DOCNO>
	<brief_summary>The overall aim project provide proof-of-principle biofortification cassava vitamin A viable strategy improve vitamin A status deficient population .</brief_summary>
	<brief_title>Efficacy Yellow Cassava Improve Vitamin A Status Kenyan School Children</brief_title>
	<detailed_description>Rationale : Vitamin A deficiency still common develop country proven difficult combat . A promising approach replace common crop variety naturally richer vitamin A , referred biofortification . For cassava , yellow β-carotene rich variety recently introduce Kenya , variety ready test efficacy improve vitamin A status human . Objective : The primary objective measure effect daily consumption provitamin A biofortified cassava ( provide 50 % age-specific RDA ) vitamin A status child age 5-13 year mild moderate vitamin A deficiency Kenya . To determine bioefficacy provitamin A carotenoid biofortified cassava relative daily B-carotene supplement ( comparison positive control group ) . Secondary objective : 1 ) measure effect intervention immune function indicator morbidity ; 2 ) determine degree serum retinol response intervention depend serum concentration retinol zinc baseline ; 3 ) determine effect intervention functional indicator dark adaptation capacity , gut integrity , hematology indicator thyroid status ; 4 ) determine mediate effect SNP 's BCMO1 gene treatment outcome . Study design &amp; Study population : In randomize controlled trial , school child age 5-13 year live Kibwezi area , Kenya . Children select three ( four ) primary school area pre-selected base prevalence vitamin A deficiency , location willingness participate . Intervention : After screen eligibility 2-week run-in period ( n=360 ) Children randomly allocate three different treatment : 1 ) 400 g yellow cassava provide ~50 % RDA vitamin A ; placebo capsule ; 2 ) 400 g white cassava ; placebo capsule ; 3 ) 400 g white cassava capsule contain 100 RAE all-trans β-carotene . Main study parameters/endpoints : The main outcome measure difference serum retinol concentration group . Other outcome measure include vitamin A status indicator ( β-carotene , retinol binding protein , transthyretin ) , immune function indicator , dark adaptation , iron status indicator , anthropometrics , gut integrity , thyroid function .</detailed_description>
	<mesh_term>Vitamin A Deficiency</mesh_term>
	<mesh_term>Night Blindness</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Beta Carotene</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>Low vitamin A status ( retinol bind protein ( RBP ) low end distribution include study ) History sign infectious systemic disease ( e.g . tuberculosis , sickle cell anaemia ) Anaemia , malaria acute inflammation day baseline measurement</criteria>
	<gender>All</gender>
	<minimum_age>61 Months</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Vitamin A deficiency</keyword>
	<keyword>Biofortification</keyword>
	<keyword>Cassava</keyword>
	<keyword>B-carotene</keyword>
	<keyword>School child</keyword>
	<keyword>Kenya</keyword>
</DOC>